Advanced search
Publication Cover
Infection and Drug Resistance Volume 14, 2021 - Issue
Submit an article Journal homepage
184
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Phenotypic and Genotypic Drug Susceptibility Assessment of Mycobacterium bovis Bacillus Calmette-Guérin Clinical Strains

Maria Carolina Sisco1 Laboratório de Micobactérias, Departamento de Microbiologia Médica, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil;2 Laboratório de Biologia Molecular Aplicada às Micobactérias, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil
,
Marlei Gomes da Silva1 Laboratório de Micobactérias, Departamento de Microbiologia Médica, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
,
Luciana Distasio de Carvalho3 Laboratório de Referência Nacional Para Tuberculose e Micobacterioses, Centro de Referência Professor Hélio Fraga, Escola Nacional de Saúde Pública, Rio de Janeiro, Brazil
,
Carlos Eduardo Dias Campos3 Laboratório de Referência Nacional Para Tuberculose e Micobacterioses, Centro de Referência Professor Hélio Fraga, Escola Nacional de Saúde Pública, Rio de Janeiro, Brazil
,
Paulo Cesar De Souza Caldas3 Laboratório de Referência Nacional Para Tuberculose e Micobacterioses, Centro de Referência Professor Hélio Fraga, Escola Nacional de Saúde Pública, Rio de Janeiro, Brazil
,
Beatriz Lopez4 Instituto Nacional de Enfermedades Infecciosas, Buenos Aires, ArgentinaORCID Iconhttps://orcid.org/0000-0003-1212-7810
ORCID Icon,
Claudia Argüelles5 Instituto Nacional de Producción de Biológicos – ANLIS Carlos G Malbrán, Buenos Aires, Argentina
,
Ana Carolina Carvalho6 Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Campus Macaé, Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0002-1163-3407
ORCID Icon,
Jacobus de Waard7 Departamento de Tuberculosis, Instituto Autónomo de Biomedicina Dr. Jacinto Convit, Caracas, Venezuela;8 One Health Research Group, Facultad de Ciencias de La Salud, Universidad de Las Américas, Quito, EcuadorORCID Iconhttps://orcid.org/0000-0003-4118-1015
ORCID Icon,
Philip Suffys2 Laboratório de Biologia Molecular Aplicada às Micobactérias, Instituto Oswaldo Cruz, Rio de Janeiro, BrazilCorrespondence[email protected]
&
Rafael Silva Duarte1 Laboratório de Micobactérias, Departamento de Microbiologia Médica, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
 show all
Pages 459-466 | Published online: 05 Feb 2021

References

  • Global tuberculosis report. World Health Organization: 2019.
  • Calmette A. Preventive vaccination against tuberculosis with BCG. Proc R Soc Med. 1931;85–94.
  • Behr MA. BCG - Different strains, different vaccines? Lancet Infect Dis. 2002;2(2):86–92. doi:10.1016/S1473-3099(02)00182-211901655
  • Brosch R, Gordon SV, Garnier T, et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A. 2007;104(13):5596–5601. doi:10.1073/pnas.070086910417372194
  • Tran V, Liu JUN, Behr MA. BCG vaccines. Microbiol Spectrum. 2014;2(1):1–11. doi:10.1128/microbiolspec.MGM2-0028-2013
  • Zhang L, Ru HW, Chen FZ, et al. Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms. Mol Ther. 2016;24(2):398–405. doi:10.1038/mt.2015.21626643797
  • Barker LF. The Immunological Basis for Immunization Series. Module 5: Tuberculosis. Geneva: World Health Organization; 2011:29.
  • Talbot EA, Perkins MD, Silva SF, Frothingham R. Disseminated bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis. 1997;24(6):1139–1146. doi:10.1086/5136429195072
  • Hesseling AC, Schaaf HS, Victor T, et al. Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23(5):476–479. doi:10.1097/01.inf.0000126593.21006.ac15131480
  • Diniz LM, Guimarães T, Oliveira M, Pinto JA, Miranda SS. Lymphadenitis caused by infection with an isoniazid- and rifampin-resistant strain of Mycobacterium bovis BCG in an infant with IFN-γ/IL-12 pathway defect. J Bras Pneumol. 2014;40(2):188–192. doi:10.1590/S1806-3713201400020001424831405
  • Gomes LHF, Otto TD, Vasconcellos ÉA, et al. Genome sequence of Mycobacterium bovis BCG Moreau, the Brazilian vaccine strain against tuberculosis. J Bacteriol. 2011;193(19):5600–5601. doi:10.1128/JB.05827-1121914899
  • Sotnikova EA, Shitikov EA, Malakhova MV, et al. Complete genome sequence of Mycobacterium bovis strain BCG-1 (Russia). Genome Announc. 2016;4(2):2007–2008.
  • Schoutrop ELM, Brouwer MAE, Jenniskens JCA, et al. The stability of antimycobacterial drugs in media used for drug susceptibility testing. Diagn Microbiol Infect Dis. 2018;92(4):305–308. doi:10.1016/j.diagmicrobio.2018.06.01530025972
  • Griffith ME, Bodily HL. Stability of antimycobacterial drugs in susceptibility testing. Antimicrob Agents Chemother. 1992;36(11):2398–2402. doi:10.1128/AAC.36.11.23981489183
  • Ruesen C, Riza AL, Florescu A, et al. Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania. Sci Rep. 2018;8(1):9676. doi:10.1038/s41598-018-27962-529946139
  • Williamson DA, Roberts SA, Bower JE, et al. Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2012;16(2):216–220. doi:10.5588/ijtld.11.017822137551
  • Ho J, Jelfs P, Sintchencko V. Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment. J Antimicrob Chemother. 2013;68(12):2915–2920. doi:10.1093/jac/dkt28423838950
  • Kanji A, Hasan R, Hasan Z. Efflux pump as alternate mechanism for drug resistance in Mycobacterium tuberculosis. Indian J Tuberc. 2019;66(1):20–25. doi:10.1016/j.ijtb.2018.07.00830797276
  • Ritz N, Tebruegge M, Connell TG, Sievers A, Robins-Browne R, Curtis N. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. Antimicrob Agents Chemother. 2009;53(1):316–318. doi:10.1128/AAC.01302-0818955515
  • Watts MR, Taylor PC, Sintchenko V, et al. Editor’s choice: implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer. Clin Infect Dis. 2011;52(1):86–88. doi:10.1093/cid/ciq00221148524
  • WHO Discussion on the Improvement of the Quality Control of BCG Vaccines. França: World Health Organization; 2005.
  • Arend SM, Van Soolingen D. Low level INH-resistant BCG: a sheep in wolf’s clothing? 2011;89–93. doi:10.1093/cid/ciq016

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.